Charles River Laboratories International, Inc. (CRL)

NYSE - NYSE Delayed Price. Currency in USD

Add to watchlist

242.92

+1.84

(+0.76%)

At close: 01:00PM EST

242.92

0.00

(0.00%)

After hours:

01:15PM EST

Loading interactive chart...

Business Wire
Charles River Laboratories to Present at November Investor Conferences
WILMINGTON, Mass., November 14, 2022--Charles River Laboratories To Present At November Investor Conferences
Business Wire
Charles River Laboratories Demonstrates Excellence in Advanced Modalities at Neuroscience 2022
WILMINGTON, Mass., November 10, 2022--Charles River announced that its team of neuroscience drug discovery experts will present 23 scientific posters at Neuroscience 2022.
Business Wire
Charles River Announces Cell Therapy Manufacturing Capacity Expansion, Reinforcing Commitment to CDMO Clients
MEMPHIS, Tenn., November 07, 2022--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the expansion of its cell therapy contract development and manufacturing (CDMO) facility in Memphis, Tenn. The expanded space is suitable for clinical and commercial cell therapy manufacturing, with an additional nine (9) state-of-the-art processing suites, adding to an existing 16 cleanrooms.